"Tardive" means late, and "dyskinesia" means uncontrolled movements. It's often a side effect of medication that blocks dopamine in your brain. That's a brain chemical to help your nerves and body ...

There are currently only two medications approved by the Food and Drug Administration (FDA) available to manage tardive dyskinesia, deutetrabenazine (Austedo) and valbenazine (Ingrezza).

The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...

Coherent Market Insights has announced new analysis on Tardive Dyskinesia Drugs Market Status 2022-2028 which has been prepared based on an in-depth Market analysis with inputs from industry ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the long-term, open-label KINECT® 4 study demonstrating remission of tardive dyskinesia among the majority of patients treated ...

JOY ANTONELLE DE MARCAIDA Yes. I think that it's important for people to understand how tardive dyskinesia is manifest, and whether there are treatment options that we can offer. Certainly.

“These findings further establish Ingrezza as a highly effective long-term treatment option for individuals living with tardive dyskinesia, regardless of their underlying psychiatric ...

Neurocrine (NBIX) presented new data from the long-term, open-label KINECT 4 study demonstrating remission of tardive dyskinesia among the ...

Five differential metabolites had AUC values greater than 0.7 for diagnosing tardive dyskinesia in schizophrenia ...

Differentiating tardive dyskinesia from other movement disorders can be challenging. "One major criterion is the history of exposure to neuroleptic medications," said Jeff Bronstein, MD ...

“Tardive” means delayed and “dyskinesia” means abnormal involuntary movement. The problem is caused by exposure to medications that block dopamine receptors (most commonly certain antidepressant, ...

Ask the Expert: Joseph Jankovic, MD, on Tardive Dyskinesia Newer dopamine receptor blocking drugs and dopamine depleting drugs have shown promise in lowering the risk of tardive dyskinesia.